| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $58K | — | -77.7% |
| SG&A Expense | $1.2M | — | -33.9% |
| Operating Income | -$1.3M | — | +39.2% |
| Net Income | -$1.8M | — | +20.5% |
| EPS (Basic) | -$0.22 | — | +69.9% |
| EPS (Diluted) | -$0.22 | — | +69.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $742K | +113.3% | -64.8% |
| Total Assets | $742K | +113.3% | -96.5% |
| Current Liabilities | $14.9M | +16.7% | +23.9% |
| Total Liabilities | $14.9M | +16.7% | +15.6% |
| Stockholders' Equity | -$14.1M | -14.0% | -273.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$799K | — | +54.9% |
| Financing Cash Flow | $1.0M | — | -46.0% |